En un mundo donde la inteligencia y el intelecto son altamente valorados, existe un club exclusivo que reúne a algunas de las mentes más brillantes del planeta. Mensa, conocido como el “club de los genios”, se ha convertido en un referente para aquellos que buscan desafiar su …
Pi, esa constante matemática que ha fascinado a científicos y matemáticos durante siglos, ha sido objeto de estudio y cálculo exhaustivo. A lo largo de la historia, las mentes brillantes se han esforzado por desentrañar los misterios de este número irraciona …
XNK Therapeutics AB announced that two posters, regarding bladder cancer and acute myeloid leukemia respectively, will be presented at the 20th Meeting of the Society for Natural Immunity in Oslo, Norway, in September
XNK Therapeutics to present two posters at the NK2023 conference in Oslo in September Read More »
ImPact Biotech recently announced an agreement with Maastricht University to collaborate in research focused on eye treatment to arrest the progression of the severe eye disease Pathological Myopia, also known as Myopic Macular Degeneration.
Bio-Thera Solutions, Ltd announced positive Phase 1 clinical data for BAT8006 as part of a presentation of the clinical results of a Phase 1 dose escalation study evaluating the safety and efficacy of BAT8006 at the Bethune Obstetrics and Gynecology Forum in China.
Kelyniam Global, a maker of custom cranial implants, announced results for its half year ended June 30, 2023.
Kelyniam Global Releases 2nd Quarter 2023 Financials Read More »
Insilico’s AI platform has attracted interest from a growing number of biopharma companies. Meanwhile, several other firms highlight their own AI technologies.
Launch of Insilico’s Phase II Program Highlights Generative AI Momentum Read More »
With a potential $509 billion up for grabs by 2028, companies including Biogen, Sage, Karuna Therapeutics and Cerevel Therapeutics are vying to bring their drugs across the regulatory finish line.
The Neuropsychiatric Pipeline: 10 Late-Stage Therapies to Watch Read More »
The FDA has four decisions on deck this week, including ones for two rare disease treatments from Ipsen and Regeneron.
FDA Action Alert: Ipsen, Revance, Neurocrine and Regeneron Read More »
El realizador audiovisual estrenará el cortometraje “The Present” sobre Dimitri Poffé, quien, tras un test genético, se dedicó a viajar y crear conciencia sobre esta patología. Para Dhalleine, “el arte es la mejor manera de conectar al público con lo que importa”.
